Literature DB >> 7048082

Screening of antioxidants and other compounds for antimutagenic properties towards benzo[a]pyrene-induced mutagenicity in strain TA98 of Salmonella typhimurium.

L M Calle, P D Sullivan.   

Abstract

Antioxidants and several other compounds, some of which are known to inhibit carcinogenicity, have been screened for their effectiveness as inhibitors of benzo[a]pyrene (BP) mutagenicity towards Salmonella typhimurium strain TA98 in the Ames test. A total of 32 compounds were tested. In the assay, metabolic activation of BP (8.2 nmoles/plate) was mediated by the S9 fraction from beta-naphthoflavone-induced rat livers. Among compounds which are known to inhibit carcinogenicity, retinol, phenothiazine, disulfiram, phenethylisothiocyanate and phenylisothiocyanate were the most effective inhibitors of BP mutagenicity, being effective at equimolar concentrations. Several other compounds showed inhibition at higher concentrations of antioxidant and the remainder showed little or no inhibition. Dose-response curves have been obtained for the 17 most active compounds. No general pattern of inhibition is obvious from our studies, inhibitors are not drawn ;from any single class of compounds, nor does a particular compound necessarily appear to inhibit more than one mutagen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048082     DOI: 10.1016/0165-1218(82)90001-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Medicinal plants in therapy.

Authors:  N R Farnsworth; O Akerele; A S Bingel; D D Soejarto; Z Guo
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  Interaction between dietary selenium and 2-acetylaminofluorene in the rat.

Authors:  A M Cohen
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

3.  Forestomach neoplasm induction in F344/DuCrj rats and B6C3F1 mice exposed to sesamol.

Authors:  S Tamano; M Hirose; H Tanaka; E Asakawa; K Ogawa; N Ito
Journal:  Jpn J Cancer Res       Date:  1992-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.